NCT05550194View on ClinicalTrials.gov

VZV in the Enteric Nervous System: Pathogenesis and Consequences

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Achalasia
Interventions
DRUG

ValACYclovir 1000 MG

Valacyclcovir is a targeted anti-viral for varicella zoster virus (VZV).

BIOLOGICAL

Shingrix

Vaccine indicated for prevention of herpes zoster

Trial Locations (1)

37129

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Columbia University

OTHER

lead

Vanderbilt University Medical Center

OTHER